Cargando…

Increased risk of immune thrombocytopenia following AstraZeneca Covid-19 vaccine

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8602539/
http://dx.doi.org/10.1007/s40278-021-05476-5
_version_ 1784601597335044096
collection PubMed
description
format Online
Article
Text
id pubmed-8602539
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-86025392021-11-19 Increased risk of immune thrombocytopenia following AstraZeneca Covid-19 vaccine Reactions Weekly Clinical Study Springer International Publishing 2021-11-20 2021 /pmc/articles/PMC8602539/ http://dx.doi.org/10.1007/s40278-021-05476-5 Text en © Springer International Publishing AG 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Clinical Study
Increased risk of immune thrombocytopenia following AstraZeneca Covid-19 vaccine
title Increased risk of immune thrombocytopenia following AstraZeneca Covid-19 vaccine
title_full Increased risk of immune thrombocytopenia following AstraZeneca Covid-19 vaccine
title_fullStr Increased risk of immune thrombocytopenia following AstraZeneca Covid-19 vaccine
title_full_unstemmed Increased risk of immune thrombocytopenia following AstraZeneca Covid-19 vaccine
title_short Increased risk of immune thrombocytopenia following AstraZeneca Covid-19 vaccine
title_sort increased risk of immune thrombocytopenia following astrazeneca covid-19 vaccine
topic Clinical Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8602539/
http://dx.doi.org/10.1007/s40278-021-05476-5